Product links
No direct Denser product mapped yet. Still useful for comparison and education.
Evidence Grade
C
Linked Papers
4
Participants
N/A
Average Efficacy
Pending
Summary
4 linked papers with evidence grade C.
Best indexed study: New Treatments for Hair Loss. (2018)
Side Effects
No structured side-effect extraction yet.
Linked studies
Clinical, cosmetic and investigational dermatology · 2023 · Kaiser M, Abdin R, Gaumond SI, Issa NT, Jimenez JJ
Confidence
low
Standard treatments like topical minoxidil and oral finasteride are established, while newer modalities like PRP, LLLT, and oral minoxidil show encouraging results but lack standardized protocols.
Extracted key result
Pending structured analysis
Sample size not extracted
Faculty reviews · 2022 · Wall D, Meah N, Fagan N, York K, Sinclair R
Confidence
low
The review outlines various current and emerging therapies for hair loss, including pharmacological agents, devices, and cellular therapies.
Extracted key result
Pending structured analysis
Sample size not extracted
Regenerative therapy · 2022 · Shimizu Y, Ntege EH, Sunami H, Inoue Y
Confidence
low
The review identifies MSC implantation, MSC-derived secretome, and PRP as promising regenerative treatment options for alopecia, though further clinical application strategies are needed.
Extracted key result
Pending structured analysis
Sample size not extracted
Actas dermo-sifiliograficas · 2018 · Vañó-Galván S, Camacho F
Confidence
moderate
The review highlights several emerging therapies, including novel excipients for oral minoxidil, dutasteride, and finasteride; topical prostaglandin modulators; low-level laser therapy; Wnt pathway activators and stem cell treatments for androgenetic alopecia; JAK inhibitors for alopecia areata; antiandrogens and pioglitazone for frontal fibrosing alopecia; and robotic-assisted follicular unit extraction for hair transplantation.
Extracted key result
Pending structured analysis
Sample size not extracted